Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Cheryl Lai-Lai Chiang, Klara Balint, George Coukos & Lana E Kandalaft. (2015) Potential approaches for more successful dendritic cell-based immunotherapy. Expert Opinion on Biological Therapy 15:4, pages 569-582.
Read now
Read now
Erika Vacchelli, Alexander Eggermont, Catherine Sautès-Fridman, Jérôme Galon, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2013) Trial watch. OncoImmunology 2:6.
Read now
Read now
Christina S Chu, Sarah H Kim, Carl H June & George Coukos. (2008) Immunotherapy opportunities in ovarian cancer. Expert Review of Anticancer Therapy 8:2, pages 243-257.
Read now
Read now
George Coukos, Jose R Conejo-Garcia, Richard BS Roden & T-C Wu. (2005) Immunotherapy for gynaecological malignancies. Expert Opinion on Biological Therapy 5:9, pages 1193-1210.
Read now
Read now
Articles from other publishers (27)
Federico Armando, Matteo Gambini, Attilio Corradi, Kathrin Becker, Katarzyna Marek, Vanessa Maria Pfankuche, Ahmed Elmonastir Mergani, Graham Brogden, Nicole Buhr, Maren Köckritz‐Blickwede, Hassan Y. Naim, Wolfgang Baumgärtner & Christina Puff. (2020) Mesenchymal to epithelial transition driven by canine distemper virus infection of canine histiocytic sarcoma cells contributes to a reduced cell motility in vitro. Journal of Cellular and Molecular Medicine 24:16, pages 9332-9348.
Crossref
Crossref
Federico Armando, Matteo Gambini, Attilio Corradi, Chiara Giudice, Vanessa Maria Pfankuche, Graham Brogden, Friederike Attig, Maren von Köckritz-Blickwede, Wolfgang Baumgärtner & Christina Puff. (2020) Oxidative Stress in Canine Histiocytic Sarcoma Cells Induced by an Infection with Canine Distemper Virus Led to a Dysregulation of HIF-1α Downstream Pathway Resulting in a Reduced Expression of VEGF-B In Vitro. Viruses 12:2, pages 200.
Crossref
Crossref
Jiayun Yu, Bin Shao, Min Luo, Wei Du, Wen Nie, Jingyun Yang & Xiawei Wei. (2020) Irradiated lactic acid-stimulated tumour cells promote the antitumour immunity as a therapeutic vaccine. Cancer Letters 469, pages 367-379.
Crossref
Crossref
A. Tsun, X. N. Miao, C. M. Wang & D. C. Yu. 2016. Progress in Cancer Immunotherapy. Progress in Cancer Immunotherapy
241
283
.
Sandeep S Patil, Ivaylo Gentschev, Ingo Nolte, Gregory Ogilvie & Aladar A Szalay. (2012) Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients. Journal of Translational Medicine 10:1.
Crossref
Crossref
M.G. Bourke, S. Salwa, K.J. Harrington, M.J. Kucharczyk, P.F. Forde, M. de Kruijf, D. Soden, M. Tangney, J.K. Collins & G.C. O’Sullivan. (2011) The emerging role of viruses in the treatment of solid tumours. Cancer Treatment Reviews 37:8, pages 618-632.
Crossref
Crossref
Cheryl Lai-Lai Chiang, Fabian Benencia & George Coukos. (2010) Whole tumor antigen vaccines. Seminars in Immunology 22:3, pages 132-143.
Crossref
Crossref
Yoshihiro Ikeda, Toru Kojima, Shinji Kuroda, Yoshikatsu Endo, Ryo Sakai, Masayoshi Hioki, Hiroyuki Kishimoto, Futoshi Uno, Shunsuke Kagawa, Yuichi Watanabe, Yuuri Hashimoto, Yasuo Urata, Noriaki Tanaka & Toshiyoshi Fujiwara. (2009) A Novel Antiangiogenic Effect for Telomerase-Specific Virotherapy through Host Immune System. The Journal of Immunology 182:3, pages 1763-1769.
Crossref
Crossref
Volker Schirrmacher & Philippe Fournier. 2009. Gene Therapy of Cancer. Gene Therapy of Cancer
565
605
.
F Errington, C L White, K R Twigger, A Rose, K Scott, L Steele, L J Ilett, R Prestwich, H S Pandha, M Coffey, P Selby, R Vile, K J Harrington & A A Melcher. (2008) Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma. Gene Therapy 15:18, pages 1257-1270.
Crossref
Crossref
M C Courrèges, F Benencia, J R Conejo-García, L Zhang & G Coukos. (2005) Preparation of apoptotic tumor cells with replication-incompetent HSV augments the efficacy of dendritic cell vaccines. Cancer Gene Therapy 13:2, pages 182-193.
Crossref
Crossref
Ralf Kleef & E. Dieter Hager. 2006. Hyperthermia in Cancer Treatment: A Primer. Hyperthermia in Cancer Treatment: A Primer
276
337
.
S. Finke & K.-K. Conzelmann. 2005. The World of Rhabdoviruses. The World of Rhabdoviruses
165
200
.
P. Moingeon. (2001) Cancer vaccines. Vaccine 19:11-12, pages 1305-1326.
Crossref
Crossref
Timothy A. Steele. (2008) Recent Developments in the Virus Therapy of Cancer. Proceedings of the Society for Experimental Biology and Medicine 223:2, pages 118-127.
Crossref
Crossref
Timothy A. Steele. (2000) Recent Developments in the Virus Therapy of Cancer. Proceedings of the Society for Experimental Biology and Medicine 223:2, pages 118-127.
Crossref
Crossref
Joseph G. Sinkovics & Joseph C. Horvath. (2000) Newcastle disease virus (NDV): brief history of its oncolytic strains. Journal of Clinical Virology 16:1, pages 1-15.
Crossref
Crossref
J. C. HorvathAndrea HorakJ. G. SinkovicsMary PritchardStacia PendletonElizabeth Horvath. (1999) CANCER VACCINES WITH EMPHASIS ON A VIRAL ONCOLYSATE MELANOMA VACCINE. Acta Microbiologica et Immunologica Hungarica 46:1, pages 1-20.
Crossref
Crossref
Franak M. Batliwalla, Barbara A. Bateman, Davide Serrano, Douglas Murray, Stuart Macphail, V. C. Maino, John C. Ansel, Peter K. Gregersen & Cheryl A. Armstrong. (1998) A 15-Year Follow-up of AJCC Stage III Malignant Melanoma Patients Treated Postsurgically with Newcastle Disease Virus (NDV) Oncolysate and Determination of Alterations in the CD8 T Cell Repertoire. Molecular Medicine 4:12, pages 783-794.
Crossref
Crossref
Volker Schirrmacher & Claudia Haas. 1998. Gene Therapy of Cancer. Gene Therapy of Cancer
251
257
.
Kumiko Saeki, Akira Yuo, Mitsuyasu Kato, Kohei Miyazono, Yoshio Yazaki & Fumimaro Takaku. (1997) Cell Density-dependent Apoptosis in HL-60 Cells, Which Is Mediated by an Unknown Soluble Factor, Is Inhibited By Transforming Growth Factor β1 and Overexpression of Bcl-2. Journal of Biological Chemistry 272:32, pages 20003-20010.
Crossref
Crossref
Ulrich Zorn, Stefan Duensing, Frauke Langkopf, Gerasimos Anastassiou, Hartmut Kirchner, Martin Hadam, Josef Knüver-Hopf & Jens Atzpodien. (1997) Active Specific Immunotherapy of Renal Cell Carcinoma: Cellular and Humoral Immune Responses. Cancer Biotherapy and Radiopharmaceuticals 12:3, pages 157-165.
Crossref
Crossref
Junsuke Nishikawa, Yoshifumi Takeyama, Takashi Ueda, Yuichi Hori, Nozomi Ueno, Masahiro Yamamoto & Yoichi Saitoh. (1995) Induction of apoptotic cell death by pancreatitis-associated ascitic fluid in Madin-Darby canine kidney cells. FEBS Letters 373:1, pages 19-22.
Crossref
Crossref
J.G. Sinkovics & J. Horvath. (1995) Can virus therapy of human cancer be improved by apoptosis induction?. Medical Hypotheses 44:5, pages 359-368.
Crossref
Crossref
Beverly Z. Packard & Gordon Parry. (1994) Bone marrow activation by immobilized antibodies against tumor cells and immunocytes as a potential cancer immunotherapy. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1224:3, pages 395-400.
Crossref
Crossref
Ulrich Zorn, Iris Dallmann, Jens Große, Hartmut Kirchner, Hubert Poliwoda & Jens Atzpodien. (1994) Induction of Cytokines and Cytotoxicity against Tumor Cells by Newcastle Disease Virus. Cancer Biotherapy 9:3, pages 225-235.
Crossref
Crossref
VOLKER SCHIRRMACHER, HANS-JÖRG SCHILD, BRIGITTE GÜCKEL & PAUL VON HOEGEN. (1993) Tumour-Specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens. Immunology and Cell Biology 71:4, pages 311-326.
Crossref
Crossref